Picture of Avrobio logo

AVRO Avrobio Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Avrobio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-18.6-46.4-73-120-119
Depreciation
Non-Cash Items0.6354.156.6315.518.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.594.18-2.184.241.3
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-16.4-37.6-67.7-98.8-98
Capital Expenditures-0.383-1.83-1.58-1.18-2.46
Purchase of Fixed Assets
Cash from Investing Activities-0.383-1.83-1.58-1.18-2.46
Financing Cash Flow Items-0.044-20-0.308
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities17.416013017330.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.60612160.772.6-70.1

Or unlock with your email

Or unlock with your email